PUBLISHER: Frost & Sullivan | PRODUCT CODE: 2165802
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 2165802
The rapid adoption of GLP-1 therapies is reshaping the weight management landscape and creating a new set of nutritional needs among consumers using these treatments. While GLP-1 therapies have demonstrated significant benefits for weight loss and metabolic health, associated challenges-including reduced appetite and food intake, loss of lean muscle mass, digestive discomfort, inadequate nutrient intake, and hydration concerns-are creating opportunities for the nutraceutical industry to develop targeted nutritional solutions.
This study examines the impact of growing GLP-1 adoption on the global nutraceutical ingredients market, assessing how evolving consumer needs are influencing demand across key categories including muscle preservation ingredients, digestive comfort and satiety, hydration and energy support, and nutrient inadequacy. The analysis evaluates the current and future GLP-1 user base, regional adoption patterns, and the resulting implications for nutraceutical ingredient demand.
The study further identifies high-potential ingredients that can address the nutritional challenges associated with GLP-1 therapy, including proteins, essential amino acids, creatine, HMB, collagen peptides, and omega-3 fatty acids. It also explores emerging opportunities for ingredient suppliers, supplement brands, food and beverage manufacturers, and other ecosystem participants to develop products tailored to the evolving needs of GLP-1 users.
As GLP-1 therapies become increasingly integrated into long-term weight and metabolic health management, the intersection between pharmaceutical treatment and nutrition is expected to become an important growth frontier for the nutraceutical industry. The study provides a strategic perspective on where this convergence is creating the strongest opportunities for innovation, partnerships, and market growth.